Publications by authors named "Carla Verri"

Claim this Profile
C
Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.
Stefano Sestini, Mattia Boeri, Alfonso Marchiano, Giuseppe Pelosi, Carlotta Galeone, Carla Verri

Oncotarget· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk.
Orazio Fortunato, Cristina Borzi, Massimo Milione, Giovanni Centonze, Davide Conte, Carla Verri

Int J Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trial.
Marco Platania, Felice Pasini, Luca Porcu, Mattia Boeri, Francesco Verderame, Carla Verri

Lung Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study.
Mattia Boeri, Massimo Milione, Claudia Proto, Diego Signorelli, Giuseppe Lo Russo, Carla Verri

Clin Cancer Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement C4d-specific antibodies for the diagnosis of lung cancer.
Daniel Ajona, Marcin Okrój, María J Pajares, Jackeline Agorreta, María D Lozano, Carla Verri

Oncotarget· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening.
Mavis Mensah, Cristina Borzi, Carla Verri, Paola Suatoni, Davide Conte

J Vis Exp· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers.
Carla Verri, Cristina Borzi, Todd Holscher, Matteo Dugo, Andrea Devecchi

J Thorac Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA Signature.
Orazio Fortunato, Carla Verri, Ugo Pastorino, Gabriella Sozzi, Mattia Boeri

Microarrays (Basel)· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.
Stefano Sestini, Mattia Boeri, Alfonso Marchiano, Giuseppe Pelosi, Carlotta Galeone, Carla Verri

Oncotarget· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel method to detect microRNAs using chip-based QuantStudio 3D digital PCR.
Davide Conte, Carla Verri, Cristina Borzi, Paola Suatoni, Ugo Pastorino

BMC Genomics· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic use of microRNAs in lung cancer.
Orazio Fortunato, Mattia Boeri, Carla Verri, Massimo Moro, Gabriella Sozzi

Biomed Res Int· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging.
Mattia Boeri, Stefano Sestini, Orazio Fortunato, Carla Verri, Paola Suatoni

Expert Rev Mol Diagn· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes.
Erica Lorenzetto, Monica Brenca, Mattia Boeri, Carla Verri, Elena Piccinin

Oncotarget· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.
Gabriella Sozzi, Mattia Boeri, Marta Rossi, Carla Verri, Paola Suatoni

J Clin Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of circulating microRNAs in plasma of lung cancer patients.
Orazio Fortunato, Mattia Boeri, Carla Verri, Davide Conte, Mavis Mensah

Molecules· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer.
Mattia Boeri, Carla Verri, Davide Conte, Luca Roz, Piergiorgio Modena

Proc Natl Acad Sci U S A· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated levels of the acute-phase serum amyloid are associated with heightened lung cancer risk.
Mattia Cremona, Elisa Calabrò, Giorgia Randi, Maida De Bortoli, Piera Mondellini, Carla Verri

Cancer· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma DNA levels in spiral CT-detected and clinically detected lung cancer patients: a validation analysis.
Luca Roz, Carla Verri, Davide Conte, Rosalba Miceli, Luigi Mariani

Lung Cancer· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project.
Carla Verri, Luca Roz, Davide Conte, Triantafillos Liloglou, Anna Livio

Am J Respir Crit Care Med· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective study.
Gabriella Sozzi, Luca Roz, Davide Conte, Luigi Mariani, Francesca Andriani, Carla Verri

Am J Respir Crit Care Med· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis